Navigation Links
Japan on the rebound: Implications for Midwest

A favorite topic of mine over the years is Japan. In this column, I have covered different aspects of the Japanese pharmaceutical industry and biotech markets (3/10/03, 8/18/03, 3/28/05). I had the good fortune to return to Japan for the Bio-Jan 2006 Conference in September after a three-yea......

Full article >>> >
Mayor Daley's head of transportation accompanied us on this trip to Japan and came away wowed by the Japanese approach to mass transit. Many more people in Japan use mass transit, a combination of an extensive network of easy-to-use subways and trains, including the high-speed bullet trains - the Shinkansen - than in Chicago.

Upon arriving to Osaka for the Bio-Japan Conference, att......

Full article >>> e over-the-counter (OTC) drugs.

This level compares with the U.S. market, which had pharmaceutical sales of $240.3 billion in 2005, represented 44 percent of the total market, and grew three percent. So the U.S. market is about four times as large as the Japanese market, but remember that the U.S. population is about three times that of Japan (the Japanese population, at about 127 million......

Full article >>> but bi-annual price reductions of eight to 12 percent (although there is talk of reducing prices on an annual basis.) This is another factor driving Japanese companies to merge for greater critical mass (particularly in R&D) and expand their presence in the United States.

The Japanese pharma industry has been slow to embrace the successful pathway used by its automotive counterparts. Neve......

Full article >>> d>Shionogi & Co. (Osaka)$1.7<1%>$0.2+20%49Dainippon Sumitomo Pharma Co. ** (Osaka)New Jersey$1.6+30%$0.1122%Source: MedAd News, Sept. 2006
*now owned by Hoffman LaRoche
**represents merger during last 2 years

Note: sales number vary slig......

Full article >>> >$1.4+23%15.2%17Daiichi Sankyo$1.4+9%20.9%20Astellas Pharma$1.2+11%16.2%23Eisai$0.8+19%16.0%34Chugai$0.4+4%11.8%37Mitsubishi Pharma
Full article >>> ties have gotten on the biotech bandwagon. University professors now are allowed to spend time with start-up companies and share in revenue from out-licensed technologies.

What struck me at the Bio-Japan meeting was the lack of Japanese "Big Pharma" presence at the meeting (very few were there). They seem to be missing out on the growth of their own home-grown market as a source of innova......

Full article >>> lly, the Japanese External Trade Office has a large regional presence in the Midwest with its Chicago office. JETRO played a major role at the Bio-Japan event, fostering partnering sessions and receptions.

I think the time is right for Illinois and the Midwest to build further ties to both the Japanese biotech industry and the second and third tier Japan......

Full article >>> hnology Network, LLC. (WTN). WTN, LLC, accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 10/23/06


Related biology technology :

1. Japanese delegates highlight Wisconsin at BIO Chicago
2. Japanese telecom opens liason office at UW-Platteville
3. Promega, Japanese lab announce partnership
4. Japanese institute installs Imago system
5. Wisconsin biotechs plan Japan trade mission
6. Sonic Foundry makes Japanese version of lead product
7. OpGen forges agreement with Japanese importer
8. Japanese biotech is booming and linked with Midwest
9. Japans pharma mergers will trickle to the Midwest
10. Japanese institute will develop for UWs Croquet platform
11. Doyles Japan trip opens doors and minds for Wisconsin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)...  The Board of Directors of the Pittsburgh ... only pure life sciences investment firm, today ... succession plan developed by the Nominating and Governance Committee ... (Jim) F. Jordan is selected to serve as ... Manzetti , who is elected to the position of ...
(Date:12/8/2016)... SAN DIEGO, Dec. 8, 2016  OncoSec Medical ... company developing DNA-based intratumoral cancer immunotherapies, today announced ... "We are delivering on our ... melanoma with ImmunoPulse® IL-12. We are pleased with ... melanoma combination trial, and we are focused on ...
(Date:12/8/2016)... 2016  Biotheranostics today announced that new data ... Breast Cancer Index (BCI) in identifying which patients ... at-risk for disease recurrence and might benefit from ... studies advancing the understanding of the value of ... and inform decisions related to patient treatment. These ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to control cells — optogenetics — is key to exciting advances in the ... art, spatially patterned light projected via free-space optics stimulates small, transparent organisms and ...
Breaking Biology Technology:
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
(Date:11/14/2016)... Nov. 14, 2016  xG Technology, Inc. ("xG" or ... critical wireless communications for use in challenging operating environments, ... 30, 2016. Management will hold a conference call to ... p.m. Eastern Time (details below). Key Recent ... $16 million binding agreement to acquire Vislink Communication Systems. ...
(Date:6/22/2016)... WASHINGTON , June 22, 2016 On ... highly-anticipated call to industry to share solutions for the ... by U.S. Customs and Border Protection (CBP), explains that ... nationals are departing the United States ... criminals, and to defeat imposters. Logo - ...
Breaking Biology News(10 mins):